Medtronic plc MDT is scheduled to report second-quarter fiscal 2025 results on Nov. 19, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1.23 exceeded the ...

On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...

Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...

Ilyas Khan, who is also a interventional cardiologist at the Heart Institute. AVEIR DR, developed by Abbott, is the world’s first dual chamber leadless pacemaker system designed to effectively treat ...

Medtronic’s Micra Transcatheter Pacing System (TPS), the world’s smallest pacemaker, was initially approved by the U.S. FDA in April 2016. It is less than 2.5 cm in diameter, making it a revolutionary ...

A pacemaker is a small, battery-powered device implanted in your chest to help regulate your heart rate. It consists of two main parts—a pulse generator and leads. Pulse generator: This contains the ...

Boston Scientific Corporation ... of our INGEVITY lead for conduction system pacing, which received FDA approval in the ...

Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of ...

Marlborough-based Boston Scientific increased its estimated net sales growth for 2024. Meanwhile, Thermo Fisher slightly raised its full-year adjusted earnings per share guidance. Boston ...

Erica Denhoff / Icon Sportswire via Getty Images Boston Scientific shares fell Wednesday as its third-quarter profit missed estimates. The medical device maker's adjusted earnings per share and ...

Good morning and welcome to the Boston Scientific Third ... lead for conduction system pacing, which received FDA approval in the quarter and our EMPOWUR leadless pacemaker, which we now have ...